Na, Bing
Yu, Xin
Withers, Tracy
Gilleran, John
Yao, Ming
Foo, Tzeh Keong
Chen, Chunxia
Moore, Dirk
Lin, Yong
Kimball, S. David
Xia, Bing
Ganesan, Shridar
Carpizo, Darren R.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (K08, R01)
Breast Cancer Research Foundation
American Breast Cancer Foundation
Article History
Received: 28 August 2018
Accepted: 15 March 2019
First Online: 15 April 2019
Competing interests
: D.C. is the founder and D.K. is on the scientific advisory board of Z53 Therapeutics, Inc. S.G. is a consultant for Roche, Foundation Medicine, Foghorn Therapeutics, Novartis, and Inspirata and have equity and patents licensed to Inspirata. The rest of the authors declare no competing interests.